IL6 and metabolic syndrome: These proteomic perturbations coalesce into a malnutrition-inflammation axis where sustained catabolic signaling, potentially via IL-6-mediated JAK/STAT activation (28), overrides nutritional anabolism, establishing MetS as both a biological filter and amplifier of therapeutic resistance.